MISSISSAUGA, Ontario, March 11, 2011 /PRNewswire/ — Valeant
Pharmaceuticals International, Inc. (NYSE:
VRX) (TSX: VRX) announced that effective March 10, 2011, the
company completed its previously announced acquisition of
PharmaSwiss S.A.
About Valeant Valeant Pharmaceuticals International, Inc.
(NYSE/TSX: VRX) is a multinational specialty pharmaceutical company
that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of neurology,
dermatology and branded generics. More information about
Valeant can be found at www.valeant.com.Contact
Information:Laurie W. Little949-461-6002
laurie.little@valeant.com(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)
‘/>”/>
SOURCE
